We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

JDRF and GNF Announce Innovative Diabetes Drug Discovery and Development Partnership

Program focuses on expanding pipeline of drugs for people with Type 1 Diabetes.
News

Lorus Therapeutics Announces Allowance of Patent for LOR-2040 in Japan

The Japanese patent protects LOR-2040 composition and its use in the treatment of cancer.
News

Novartis Begins Shipment of Fluvirin® Seasonal Influenza Vaccine for U.S. Market Ahead of Schedule

Company is providing 30 million doses of Fluvirin vaccine to support the annual seasonal influenza vaccination campaign.
News

Reprogramming Human Cells without Inserting Genes

Research Team at WPI and CellThera discovers a way to turn on stem cell genes in human skin cells without using viruses or inserting new genes.
News

454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright

The collaboration is aimed to sequence genomic regions associated with psychiatric disease.
News

Boston University and Bruker Establish a Collaborative Effort in Glycomics and Advanced FTMS Applications

Collaboration focuses on the application of high performance ion trap mass spectrometry and FTMS to glycomics and proteomics applications.
News

Horizon Discovery Sign License Agreement with Ortho Biotech Oncology Research & Development

The agreement covers the licensing of certain X-MAN cell lines including major cancer causing genes and their matched normal genetic backgrounds.
News

Ligand and Organon Mutually Terminate Collaboration and License Agreement

Both the companies mutually terminate collaboration and license agreement, which Ligand assumed in connection with its acquisition of Pharmacopeia in December 2008.
News

Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration

The collaboration will create antibody based products targeted to complex cell surface receptors.
News

UF Scientists Program Blood Stem Cells to Become Vision Cells

Research suggests a potential treatment for one of the most common causes of vision loss in older people.
Advertisement